Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01653366 · ClinicalTrials.gov registry record · NA

Effect of a Goal Setting Intervention on Exercise in Women With Metastatic Breast Cancer: An Exploration of The Lipogenic Pathway

A NA study, sponsored by Dartmouth-Hitchcock Medical Center.

Terminated
Registry status
NA
Development phase
4
Enrollment target

NCT01653366 is a NA study that was terminated before completion, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 4 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01653366, a NA study, was terminated before completion, sponsored by Dartmouth-Hitchcock Medical Center.

TERMINATED
Registry status
NA
Development phase
4 participants
Enrollment target

Study Summary

This study is a randomized prospective clinical trial of women with metastatic breast cancer. The purpose of the study is to test if an intervention of regular physical activity review and physical activity goal setting will allow the subjects to achieve a moderate increase in physical activity of 6,000 steps per week. The physical activity review will consist of weekly telephone call to inquire about symptoms and to set physical activity goals. The study will also look to see if the goal setting intervention will affect the time to progression, change in BMI, and quality of life. Quality of life will be measured by answers to questionnaires provided to subjects at regular intervals during the course of the study. Finally, the study will examine the impact of physical activity on expression of tumor molecular molecules, insulin levels, and estradiol levels. Through an intervention of regular physical activity review and goal setting, the investigators hypothesize that a moderate increase in level of physical activity of 6000 steps per week or more can be obtained by patients with metastatic breast cancer who receive a goal setting intervention. The investigators propose that those who are able to achieve and maintain greater than or equal to 22500 steps per week will demonstrate biologic and molecular differences compared to those who are not able to achieve that level of physical activity. The investigators expect that people who are more active will have longer to progression.

Interventions

  • BEHAVIORAL Physical Activity Goal Setting

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2012-12
Est. Completion 2016-01
Phase NA

Sponsor

Dartmouth-Hitchcock Medical Center

427 total trials

What the Registry Record Tells You About NCT01653366

The ClinicalTrials.gov registry entry for NCT01653366 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Physical Activity Goal Setting is the first listed.

NCT01653366 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01653366 about?

NCT01653366 is a clinical study titled "Effect of a Goal Setting Intervention on Exercise in Women With Metastatic Breast Cancer: An Exploration of The Lipogenic Pathway". This study is a randomized prospective clinical trial of women with metastatic breast cancer. The purpose of the study is to test if an intervention of regular physical activity review and physical activity goal setting will allow the subjects to achieve a moderate increase in physical activity of 6...

What is the current status of trial NCT01653366?

This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2012-12. Estimated completion is 2016-01.

What interventions are being tested in trial NCT01653366?

The interventions under investigation include: Physical Activity Goal Setting (BEHAVIORAL).

Who is sponsoring clinical trial NCT01653366?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.